Abstract:Objective To investingate the effect of SGK1 expression level on the prognosis of patients with NSCLC,and provide new biological predictors for the prognosis assessment of patients with NSCLS.Methods One hundred and twenty patients with NSCLC received radical resection in Hanzhong 3201 hospital from Jan 2011 to Dec 2013 were selected.There were 75 males and 45 females,age (63.15 ± 16.44) years,age range 45-80 years.According to the results of immunohistochemical staining,the SGK1 cut-off value determined by the integral was determined,and NSCLC patients were divided into SGK1 high expression group (n =70) and SGK1 low expression group(n =50).The relationship between the expression of SGK1 and clinicopathological features (age,sex,smoking history,alcoholism history,BMI,tissue type,tumor diameter,T stage,N stage,TNM stage,differentiation degree) in NSCLC were analyzed,and the overall survival rate in NSCLC were also analyzed.Followup was carried out by telephone or patient admission.The follow-up period was up to June 1,2018.Chest X-ray and ultrasonography were reviewed every 3 to 6 months after operation,and enhanced CT or MRI were performed if the results were abnormal.The measurement data conforming to normal distribution were expressed by t test and showed by (Mean ± SD);the counting data were tested by x2 test;the 5-year overall survival rate was used as the endpoint event for univariate analysis,and the significant variables for univariate analysis were analyzed by COX risk ratio model for multivariate analysis.The cumulative survival curve was drawn by Kaplan-Meier method,and the difference was tested by Log-rank method.Results The expression level of SGK1 in tissues was not related to age,sex,smoking history,alcoholism,BMI,tissue type and tumor diameter (P ＞ 0.05),but it was related to T stage,N stage,TNM stage and differentiation degree (P ＜ 0.05).The univariate and multivariate COX risk ratio model showed that TNM stage and SGK1 expression were independent factors affecting the 5-year overall survival rate of NSCLC patients (P ＜ 0.05).The results of Kaplan-Meier survival curve showed that the 5-year overall survival rate in NSCLC with low expression of SGK1 was significantly higher than that in NSCLC with high expression of SGK1 (P ＜ 0.05).Conclusions The expression of SGK1 in tissues is closely related to the prognosis of patients with NSCLC.The high expression of SGK1 in tissues is not conducive to the prognosis of patients with NSCLC.

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

Glycogen Synthase Kinase 3β Induces Apoptosis in Lung Cancer Cells Through Modulating Survivin Expression

Correlation Between Pgsk-3Β Expression and Prognosis in Non-Small Cell Lung Cancer

Overexpression of Golph3 is Associated with Poor Survival in Non-Small-Cell Lung Cancer

GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition

Glycogen synthase kinase GSK3α promotes tumorigenesis by activating HIF1/VEGFA signaling pathway in NSCLC tumor

Glycogen Synthase Kinase 3 Beta Induces Apoptosis In Cancer Cells Through Increase Of Survivin Nuclear Localization

Glycogen Synthase Kinase 3beta Induces Cell Cycle Arrest in a Cyclin D1-dependent Manner in Human Lung Adenocarcinoma Cell Line A549.

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

Role of GSK-3β Activation in Responses of Colorectal Cancer Cells to EGFR and IGFR-1 Inhibitor

Elevated Expression of G3BP1 Associates with YB1 and P‐akt and Predicts Poor Prognosis in Nonsmall Cell Lung Cancer Patients after Surgical Resection

Molecular Role of SGK3 Gene in Promoting the Progression of Non-small Cell Lung Cancer

Clinical significance of GSK3β expression in esophageal squamous cell carcinoma tissue

Relationship between serum and glucocorticoid-regulated kinase 1 expression and prognosis in patients with non-small cell lung cancer

PIG3 Promotes NSCLC Cell Mitotic Progression and is Associated with Poor Prognosis of NSCLC Patients

Glycogen Synthase Kinase 3 Beta In Tumorigenesis And Oncotherapy

Serum and Glucocorticoid-Regulated Kinase 1 (SGK1) is a Predictor of Poor Prognosis in Non-Small Cell Lung Cancer, and Its Dynamic Pattern Following Treatment with SGK1 Inhibitor and Γ-Ray Irradiation Was Elucidated.

Shrna Silencing Glycogen Synthase Kinase-3 Beta Inhibits Tumor Growth and Angiogenesis in Pancreatic Cancer

Effects of Glycogen Synthase Kinase3β Silencing on Cell Growth and Epithelial-Mesenchymal Transition in Pancreatic Cancer PANC1 Cells

Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway